New: Compliance Automation Reduces Risk and Time Pharma Solutions is the exclusive partner and distributor of LighthouseAI™, a comprehensive AI-based compliance solution to mitigate risk and manage the rapid pace of regulatory change while reducing the time and cost...
Proposed Rules for DEA Suspicious Orders In November 2020, the Drug Enforcement Administration (DEA) issued a Notice of Proposed Rulemaking (NPRM)...
Changes Rumored to Be on Horizon for DEA Suspicious Orders Public interest in the Opioid Epidemic has taken a back seat to this year’s events...
Over two years in the making, the light at the end of the tunnel is finally in sight – the Drug Enforcement Administration’s (DEA) update to the infamous definition of a “suspicious order” may only be a few months away. In Fall 2017, the DEA drafted proposed an update to “to revise its regulations relating to suspicious orders of controlled substances,” per RIN 1117-AB47. The new rule will also further specify “the procedures a registrant must follow upon receiving such orders.”
DEA Consultant Receives Public Backlash & New Developments Demetra Ashley spent three decades at the DEA specializing in the diversion of...
Pharma Solutions and QPharma Announce Partnership for Comprehensive DEA Compliance Software Solution Pharmaceutical compliance partnership allows...
DEA Insights from the 2018 DEA Diversion Conference The DEA hosted a conference in San Antonio, TX that addressed multiple aspects of how those that...
